View Clinical Trial (Medical Research Study)
Effect of Age on the Renal Clearance of Adefovir - NCT00187746-94143(Clinical Trial 129417)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
San Francisco |
|
State:
|
|
CA |
| Zip Code: |
|
94143 |
| Conditions: |
|
Healthy Volunteer |
| Purpose: |
|
Healthy African American subjects with normal hepatic and renal function will be
administered 10mg adefovir dipivoxil in a fasting state. Subjects will have blood and urine
collections over the following 24 hours for the measurement of adefovir renal clearance. To
investigate the role of age in renal adefovir elimination, 8 subjects will be enrolled from
each of the following age groups: 18-25 years and 48-55 years.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
1. African American (either male or female);
2. Between the ages of 18 and 25 OR between the ages of 48 and 55;
3. Healthy (no self-reported ongoing medical conditions, and no clinically significant
laboratory findings from a CBC and Complete Metabolic Panel);
4. Willing to participate in the study.
Exclusion Criteria:
1. Subject has a medical condition that increases the risks of study participation
(including pregnancy and poor renal function as defined by a calculated ClCr < 60
ml/min);
2. Any subjects with a laboratory value out of normal range and deemed to be potentially
clinically significant will be excluded. Specifically, individuals with anemia
(hemoglobin < 12 g/dL) or an elevation in liver enzymes (alanine aminotransferase,
aspartate aminotransferase, alkaline phosphatase, -glutamyltransferase) to higher
than double the respective normal value will be excluded;
3. Subject is taking any medication other than vitamins or oral contraception;
4. Subject does not consent to participate in the study. |
|
|
|
| Study is available at: |
|
San Francisco General Hospital San Francisco, CA 94143 United States
Primary Contact: Chaline Brown, PharmD Email: brownc@pharmacy.ucsf.edu Phone: 415-476-6756
Secondary Contact: Chaline Brown, PharmD Email: brownc@pharmacy.ucsf.edu Phone: 650-291-6986 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 21, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|